MedTrace Logo

Real World Glycemic Effectiveness of Linagliptin

NCT03338803 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11001

Last updated 2019-05-06

Study results available
· View outcomes & findings →

Summary

A non-interventional cohort study using existing data from patients in the Optum Clinical Database which contains electronic health record (EHR) data from providers across the United States to determine whether there is comparable effectiveness of linagliptin on glycemic effectiveness

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

Linagliptin

drug

Sponsors & Collaborators

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-21
Primary Completion
2018-02-02
Completion
2018-02-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03338803 on ClinicalTrials.gov